Thyroid Cancer
Phase 1, FIH, open-label, nonrandomized, multicenter study of JZP815 in participants with advanced or metastatic solid tumors harboring alterations in the MAPK pathway (JZ815-101)
- Details
ClinicalTrials.gov ID:
NCT05557045
Diagnosis Type:
NA
USOR Number:
- Address
,
P: